IsoPlexis - Ownership and Business Overview

Life ScienceCompany

IsoPlexis Ownership

Who owns IsoPlexis?

IsoPlexis is owned by Berkeley Lights. It was acquired on December 21, 2022.

Was IsoPlexis formerly PE-backed?

Yes. IsoPlexis was formerly owned by 2 private investors.

IsoPlexis Business Overview

Where is IsoPlexis headquartered?

IsoPlexis is headquartered in Branford, Connecticut.

What is IsoPlexis’ revenue?

IsoPlexis disclosed revenue of 17M USD for 2021 and 10M USD for 2020.

What sector is IsoPlexis in?

IsoPlexis is a life science company.

When was IsoPlexis founded?

IsoPlexis was founded in 2013.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

IsoPlexis

IsoPlexis Corp.

35 NE Industrial Road,
Branford, Connecticut 06405
United States,
(203) 208-4111
www.isoplexis.com

IsoPlexis is a life sciences company developing a diagnostic platform that identifies a wide range of patient immune responses at the cellular level. Its platform can assess safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development and informing physician decisions. IsoPlexis was founded in 2013 and is based in Branford, Connecticut.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.